Enallylpropymal

Enallylpropymal (Narconumal) is a barbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It has sedative and hypnotic effects and is considered to have a moderate abuse potential.[2]

Enallylpropymal
Clinical data
Other namesEnallylpropymal
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
ECHA InfoCard100.015.876
Chemical and physical data
FormulaC11H16N2O3
Molar mass224.256 g/mol g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  (verify)

References
  1. US Patent 2072829
  2. Eddy NB, Halbach H, Isbell H, Seevers MH. Drug dependence: Its significance and characteristics. Bulletin of the World Health Organization. 1965;32:721-733.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.